Skin filler for skin quality in women on GLP-1 medications
Part of Genetic & congenital, Skin clinical trials.
This study tests whether a hyaluronic acid filler (a common wrinkle-smoothing treatment) can improve skin quality in women who are taking GLP-1 medications for weight or diabetes. It aims to see if the filler can help with common skin changes like loss of firmness and wrinkles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 50 years old.
- You are taking a GLP-1 agonist (like Ozempic) at a stable dose for at least 6 months.
- You have moderate skin changes such as dullness, wrinkles, or loss of firmness.
- Your weight has been stable (no more than 10% change).
- You have a BMI of 27 or less.
- You are willing to maintain your current skincare routine and take birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a hyaluronic acid gel that is injected into the face to help restore volume, improve skin tightness, and reduce fine lines. It may be a good option if you have mild to moderate facial aging and want a non-surgical treatment.
This trial tests a new injectable filler made from hyaluronic acid and recombinant collagen to smooth wrinkles and add volume. It may help people who want a non-surgical option for facial rejuvenation.
This study tests a skin serum to improve facial aging signs like fine lines and dullness. It is for post-menopausal women aged 45-65 who are taking a GLP-1 medication (e.g., Ozempic, Wegovy).
This study tests a topical serum to improve visible signs of facial aging in people who are currently taking a GLP-1 medication. If you qualify, you'll use the serum for the study period and see if it helps with fine lines, sagging, and skin texture.
This study tests a treatment called poly-L-lactic acid to improve loose skin on the abdomen. It includes women who have been on a stable dose of GLP-1 medication for at least 6 months, as well as a small group who have never taken these drugs.
This trial tests whether a facial filler called Radiesse can restore volume lost during weight loss from GLP-1 medications (like Wegovy or Mounjaro). It's for adults just starting GLP-1 therapy who expect to lose 20 pounds or more and want to see if fillers can help their face look fuller.
Hear when a new Wrinkle trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.